1887

Abstract

We investigated the molecular mechanisms and clonality of imipenem-non-susceptible isolates collected during a Taiwan national surveillance programme, between 2002 and 2009. Genes for carbapenemases, plasmid-borne -type genes and extended-spectrum β-lactamase (ESBL) genes were analysed by PCR. The major porin channels OmpK35 and OmpK36 were studied by SDS-PAGE. Molecular typing was performed with pulsed-field gel electrophoresis (PFGE) and multi-locus sequence typing (MLST). Our study revealed that all 29 of the isolates tested were ESBL producers. Of the isolates collected in Taiwan from 2002 to 2009, most (84.6 %, 11/13) imipenem-resistant (MIC >2 mg l) isolates carried the gene. Isolates with an imipenem MIC of 2 mg l produced ESBLs with or without DHA-1 in combination with OmpK35/36 loss. PFGE analysis revealed that six small clusters of isolates were clonally related. The MLST grouping results were in concordance with the PFGE results. The predominant sequence types (ST) were ST11, ST48 and ST101. Two novel STs, ST1033 and ST1034, were found. The dominant clone in Taiwan, ST11, has been reported worldwide to be associated with various resistance mechanisms.

Loading

Article metrics loading...

/content/journal/jmm/10.1099/jmm.0.050492-0
2013-01-01
2024-03-28
Loading full text...

Full text loading...

/deliver/fulltext/jmm/62/1/101.html?itemId=/content/journal/jmm/10.1099/jmm.0.050492-0&mimeType=html&fmt=ahah

References

  1. Alvarez M., Tran J. H., Chow N., Jacoby G. A. 2004; Epidemiology of conjugative plasmid-mediated AmpC β-lactamases in the United States. Antimicrob Agents Chemother 48:533–537 [View Article][PubMed]
    [Google Scholar]
  2. Andrade L. N., Curiao T., Ferreira J. C., Longo J. M., Clímaco E. C., Martinez R., Bellissimo-Rodrigues F., Basile-Filho A., Evaristo M. A. other authors 2011; Dissemination of bla KPC-2 by the spread of Klebsiella pneumoniae clonal complex 258 clones (ST258, ST11, ST437) and plasmids (IncFII, IncN, IncL/M) among Enterobacteriaceae species in Brazil. Antimicrob Agents Chemother 55:3579–3583 [View Article][PubMed]
    [Google Scholar]
  3. Balm M. N., Ngan G., Jureen R., Lin R. T., Teo J. 2012; Molecular characterization of newly emerged bla KPC-2-producing Klebsiella pneumoniae in Singapore. J Clin Microbiol 50:475–476 [View Article][PubMed]
    [Google Scholar]
  4. Ben-David D., Kordevani R., Keller N., Tal I., Marzel A., Gal-Mor O., Maor Y., Rahav G. 2012; Outcome of carbapenem resistant Klebsiella pneumoniae bloodstream infections. Clin Microbiol Infect 18:54–60 [View Article][PubMed]
    [Google Scholar]
  5. Chia J. H., Su L. H., Lee M. H., Kuo A. J., Shih N. Y., Siu L. K., Wu T. L. 2010; Development of high-level carbapenem resistance in Klebsiella pneumoniae among patients with prolonged hospitalization and carbapenem exposure. Microb Drug Resist 16:317–325 [View Article][PubMed]
    [Google Scholar]
  6. Chudácková E., Bergerová T., Fajfrlík K., Cervená D., Urbásková P., Empel J., Gniadkowski M., Hrabák J. 2010; Carbapenem-nonsusceptible strains of Klebsiella pneumoniae producing SHV-5 and/or DHA-1 β-lactamases in a Czech hospital. FEMS Microbiol Lett 309:62–70[PubMed]
    [Google Scholar]
  7. CLSI 2009a Methods for Dilution Antimicrobial Susceptibility Tests for Bacteria That Grow Aerobically; Approved Standard, Eighth edition. Wayne, PA: Clinical and Laboratory Standards Institute
  8. CLSI 2009b Clinical and Laboratory Standards Institute. Performance Standards for Antimicrobial Susceptibility Testing; Twentieth Informational Supplement CLSI M100–S19-U. Clinical and Laboratory Standards Institute, Wayne, PA
  9. CLSI 2010 Clinical and Laboratory Standards Institute. Performance Standards for Antimicrobial Susceptibility Testing; Twentieth Informational Supplement CLSI M100–S20. Clinical and Laboratory Standards Institute, Wayne, PA
  10. Cuzon G., Naas T., Truong H., Villegas M. V., Wisell K. T., Carmeli Y., Gales A. C., Venezia S. N., Quinn J. P., Nordmann P. 2010; Worldwide diversity of Klebsiella pneumoniae that produce β-lactamase bla KPC-2 gene. Emerg Infect Dis 16:1349–1356 [View Article][PubMed]
    [Google Scholar]
  11. D’Agata E. M., Gerrits M. M., Tang Y. W., Samore M., Kusters J. G. 2001; Comparison of pulsed-field gel electrophoresis and amplified fragment-length polymorphism for epidemiological investigations of common nosocomial pathogens. Infect Control Hosp Epidemiol 22:550–554 [View Article][PubMed]
    [Google Scholar]
  12. Damjanova I., Tóth A., Pászti J., Hajbel-Vékony G., Jakab M., Berta J., Milch H., Füzi M. 2008; Expansion and countrywide dissemination of ST11, ST15 and ST147 ciprofloxacin-resistant CTX-M-15-type β-lactamase-producing Klebsiella pneumoniae epidemic clones in Hungary in 2005 – the new ‘MRSAs’?. J Antimicrob Chemother 62:978–985 [View Article][PubMed]
    [Google Scholar]
  13. Doumith M., Ellington M. J., Livermore D. M., Woodford N. 2009; Molecular mechanisms disrupting porin expression in ertapenem-resistant Klebsiella and Enterobacter spp. clinical isolates from the UK. J Antimicrob Chemother 63:659–667 [View Article][PubMed]
    [Google Scholar]
  14. Eckert C., Gautier V., Saladin-Allard M., Hidri N., Verdet C., Ould-Hocine Z., Barnaud G., Delisle F., Rossier A. other authors 2004; Dissemination of CTX-M-type β-lactamases among clinical isolates of Enterobacteriaceae in Paris, France. Antimicrob Agents Chemother 48:1249–1255 [View Article][PubMed]
    [Google Scholar]
  15. Giakkoupi P., Tambic-Andrasevic A., Vourli S., Skrlin J., Sestan-Crnek S., Tzouvelekis L. S., Vatopoulos A. C. 2006; Transferable DHA-1 cephalosporinase in Escherichia coli . Int J Antimicrob Agents 27:77–80 [View Article][PubMed]
    [Google Scholar]
  16. Giakkoupi P., Papagiannitsis C. C., Miriagou V., Pappa O., Polemis M., Tryfinopoulou K., Tzouvelekis L. S., Vatopoulos A. C. 2011; An update of the evolving epidemic of bla KPC-2-carrying Klebsiella pneumoniae in Greece (2009–10). J Antimicrob Chemother 66:1510–1513 [View Article][PubMed]
    [Google Scholar]
  17. Giske C. G., Fröding I., Hasan C. M., Turlej-Rogacka A., Toleman M., Livermore D. M., Woodford N., Walsh T. R. 2012; Diverse sequence types of Klebsiella pneumoniae contribute to the dissemination of bla NDM-1 in India, Sweden, and the United Kingdom. Antimicrob Agents Chemother 56:2735–2738 [View Article][PubMed]
    [Google Scholar]
  18. Gupta N., Limbago B. M., Patel J. B., Kallen A. J. 2011; Carbapenem-resistant Enterobacteriaceae: epidemiology and prevention. Clin Infect Dis 53:60–67 [View Article][PubMed]
    [Google Scholar]
  19. Hernández-Allés S., Albertí S., Alvarez D., Doménech-Sánchez A., Martínez-Martínez L., Gil J., Tomás J. M., Benedí V. J. 1999; Porin expression in clinical isolates of Klebsiella pneumoniae . Microbiology 145:673–679 [View Article][PubMed]
    [Google Scholar]
  20. Ho M., McDonald L. C., Lauderdale T. L., Yeh L. L., Chen P. C., Shiau Y. R. 1999; Surveillance of antibiotic resistance in Taiwan, 1998. J Microbiol Immunol Infect 32:239–249[PubMed]
    [Google Scholar]
  21. Hrabák J., Empel J., Bergerová T., Fajfrlík K., Urbásková P., Kern-Zdanowicz I., Hryniewicz W., Gniadkowski M. 2009; International clones of Klebsiella pneumoniae and Escherichia coli with extended-spectrum β-lactamases in a Czech hospital. J Clin Microbiol 47:3353–3357 [View Article][PubMed]
    [Google Scholar]
  22. Kitchel B., Rasheed J. K., Patel J. B., Srinivasan A., Navon-Venezia S., Carmeli Y., Brolund A., Giske C. G. 2009; Molecular epidemiology of KPC-producing Klebsiella pneumoniae isolates in the United States: clonal expansion of multilocus sequence type 258. Antimicrob Agents Chemother 53:3365–3370 [View Article][PubMed]
    [Google Scholar]
  23. Ko K. S., Lee J. Y., Baek J. Y., Suh J. Y., Lee M. Y., Choi J. Y., Yeom J. S., Kim Y. S., Jung S. I. other authors 2010; Predominance of an ST11 extended-spectrum β-lactamase-producing Klebsiella pneumoniae clone causing bacteraemia and urinary tract infections in Korea. J Med Microbiol 59:822–828 [View Article][PubMed]
    [Google Scholar]
  24. Kristóf K., Tóth A., Damjanova I., Jánvári L., Konkoly-Thege M., Kocsis B., Koncan R., Cornaglia G., Szego E. other authors 2010; Identification of a bla VIM-4 gene in the internationally successful Klebsiella pneumoniae ST11 clone and in a Klebsiella oxytoca strain in Hungary. J Antimicrob Chemother 65:1303–1305 [View Article][PubMed]
    [Google Scholar]
  25. Lauderdale T. L., Shi Z. Y., Lin C. F., Lai J. F., Tan M. C., Wang J. T., Chang S. C. 2012; KPC-2-producing sequence type 11 Klebsiella pneumoniae detected in Taiwan. Antimicrob Agents Chemother 56:2207–2208[PubMed] [CrossRef]
    [Google Scholar]
  26. Lee M. Y., Ko K. S., Kang C. I., Chung D. R., Peck K. R., Song J. H. 2011; High prevalence of CTX-M-15-producing Klebsiella pneumoniae isolates in Asian countries: diverse clones and clonal dissemination. Int J Antimicrob Agents 38:160–163 [View Article][PubMed]
    [Google Scholar]
  27. Nordmann P., Cuzon G., Naas T. 2009; The real threat of Klebsiella pneumoniae carbapenemase-producing bacteria. Lancet Infect Dis 9:228–236 [View Article][PubMed]
    [Google Scholar]
  28. Oteo J., Cuevas O., López-Rodríguez I., Banderas-Florido A., Vindel A., Pérez-Vázquez M., Bautista V., Arroyo M., García-Caballero J. other authors 2009; Emergence of CTX-M-15-producing Klebsiella pneumoniae of multilocus sequence types 1, 11, 14, 17, 20, 35 and 36 as pathogens and colonizers in newborns and adults. J Antimicrob Chemother 64:524–528 [View Article][PubMed]
    [Google Scholar]
  29. Papagiannitsis C. C., Kotsakis S. D., Petinaki E., Vatopoulos A. C., Tzelepi E., Miriagou V., Tzouvelekis L. S. 2011; Characterization of metallo-β-lactamase VIM-27, an A57S mutant of VIM-1 associated with Klebsiella pneumoniae ST147. Antimicrob Agents Chemother 55:3570–3572 [View Article][PubMed]
    [Google Scholar]
  30. Peirano G., Pillai D. R., Pitondo-Silva A., Richardson D., Pitout J. D. 2011; The characteristics of NDM-producing Klebsiella pneumoniae from Canada. Diagn Microbiol Infect Dis 71:106–109 [View Article][PubMed]
    [Google Scholar]
  31. Potron A., Kalpoe J., Poirel L., Nordmann P. 2011; European dissemination of a single OXA-48-producing Klebsiella pneumoniae clone. Clin Microbiol Infect 17:E24–E26 [View Article][PubMed]
    [Google Scholar]
  32. Qi Y., Wei Z., Ji S., Du X., Shen P., Yu Y. 2011; ST11, the dominant clone of KPC-producing Klebsiella pneumoniae in China. J Antimicrob Chemother 66:307–312 [View Article][PubMed]
    [Google Scholar]
  33. Queenan A. M., Bush K. 2007; Carbapenemases: the versatile β-lactamases. Clin Microbiol Rev 20:440–458 (table of contents.) [View Article][PubMed]
    [Google Scholar]
  34. Rasheed J. K., Jay C., Metchock B., Berkowitz F., Weigel L., Crellin J., Steward C., Hill B., Medeiros A. A., Tenover F. C. 1997; Evolution of extended-spectrum β-lactam resistance (SHV-8) in a strain of Escherichia coli during multiple episodes of bacteremia. Antimicrob Agents Chemother 41:647–653[PubMed]
    [Google Scholar]
  35. Rhee J. Y., Park Y. K., Shin J. Y., Choi J. Y., Lee M. Y., Peck K. R., Song J. H., Ko K. S. 2010; KPC-producing extreme drug-resistant Klebsiella pneumoniae isolate from a patient with diabetes mellitus and chronic renal failure on hemodialysis in South Korea. Antimicrob Agents Chemother 54:2278–2279 [View Article][PubMed]
    [Google Scholar]
  36. Samuelsen O., Toleman M. A., Hasseltvedt V., Fuursted K., Leegaard T. M., Walsh T. R., Sundsfjord A., Giske C. G. 2011; Molecular characterization of VIM-producing Klebsiella pneumoniae from Scandinavia reveals genetic relatedness with international clonal complexes encoding transferable multidrug resistance. Clin Microbiol Infect 17:1811–1816 [View Article][PubMed]
    [Google Scholar]
  37. Seki L. M., Pereira P. S., de Souza M. P., Conceição M. S., Marques E. A., Porto C. O., Colnago E. M., Alves C. F., Gomes D. other authors 2011; Molecular epidemiology of KPC-2-producing Klebsiella pneumoniae isolates in Brazil: the predominance of sequence type 437. Diagn Microbiol Infect Dis 70:274–277 [View Article][PubMed]
    [Google Scholar]
  38. Shin S. Y., Bae I. K., Kim J., Jeong S. H., Yong D., Kim J. M., Lee K. 2012; Resistance to carbapenems in sequence type 11 Klebsiella pneumoniae is related to DHA-1 and loss of OmpK35 and/or OmpK36. J Med Microbiol 61:239–245[PubMed] [CrossRef]
    [Google Scholar]
  39. Song W., Suh B., Choi J. Y., Jeong S. H., Jeon E. H., Lee Y. K., Hong S. G., Lee K. 2009; In vivo selection of carbapenem-resistant Klebsiella pneumoniae by OmpK36 loss during meropenem treatment. Diagn Microbiol Infect Dis 65:447–449 [View Article][PubMed]
    [Google Scholar]
  40. Virgincar N., Iyer S., Stacey A., Maharjan S., Pike R., Perry C., Wyeth J., Woodford N. 2011; Klebsiella pneumoniae-producing KPC carbapenemase in a district general hospital in the UK. J Hosp Infect 78:293–296 [View Article][PubMed]
    [Google Scholar]
  41. Warburg G., Hidalgo-Grass C., Partridge S. R., Tolmasky M. E., Temper V., Moses A. E., Block C., Strahilevitz J. 2012; A carbapenem-resistant Klebsiella pneumoniae epidemic clone in Jerusalem: sequence type 512 carrying a plasmid encoding aac(6′)-Ib. Antimicrob Chemother 67:898–901 [View Article]
    [Google Scholar]
  42. Woodford N., Turton J. F., Livermore D. M. 2011; Multiresistant Gram-negative bacteria: the role of high-risk clones in the dissemination of antibiotic resistance. FEMS Microbiol Rev 35:736–755 [View Article][PubMed]
    [Google Scholar]
  43. Yan J. J., Ko W. C., Tsai S. H., Wu H. M., Wu J. J. 2001; Outbreak of infection with multidrug-resistant Klebsiella pneumoniae carrying bla IMP-8 in a university medical center in Taiwan. J Clin Microbiol 39:4433–4439 [View Article][PubMed]
    [Google Scholar]
http://instance.metastore.ingenta.com/content/journal/jmm/10.1099/jmm.0.050492-0
Loading
/content/journal/jmm/10.1099/jmm.0.050492-0
Loading

Data & Media loading...

This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error